Home > Financial Ratios > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
Fixed Capital/Sales

    Back to All Ratios
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

MEDICAMEN BIOTECH Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 0.850.740.901.040.77

What is the latest Fixed Capital/Sales ratio of MEDICAMEN BIOTECH ?

The latest Fixed Capital/Sales ratio of MEDICAMEN BIOTECH is 0.85 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20250.85
Mar20240.74
Mar20230.90
Mar20221.04
Mar20210.77

How is Fixed Capital/Sales of MEDICAMEN BIOTECH Trending?

Years Fixed Capital/Sales % Change
Mar2025 0.85
14.86
Mar2024 0.74
-17.78
Mar2023 0.9
-13.46
Mar2022 1.04
35.06
Mar2021 0.77 -

Other Financial Ratios of MEDICAMEN BIOTECH


Compare Fixed Capital/Sales ratio of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹466.1 Cr -4.8% -4% -28.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹382,694.0 Cr -2.8% -7.5% -12.2% Stock Analytics
DIVIS LABORATORIES ₹160,721.0 Cr -0.6% -5.5% 6.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹134,016.0 Cr -2.5% 3.5% 21.1% Stock Analytics
CIPLA ₹106,946.0 Cr -3.7% -11.7% -8.5% Stock Analytics
DR REDDYS LABORATORIES ₹101,691.0 Cr -0.7% -4.7% -5.1% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

-4.8%

-4%

-28.1%

SENSEX

-0.1%

-2.9%

7.5%


You may also like the below Video Courses